TERRINDA ALSTON: Open Payments
NPI 1144601980 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,400 in 170 payments from 18 companies in 2025. Trend: 2023 $1,725 · 2024 $2,830 · 2025 $5,400
Food & beverage: $5,396Education: $4
| Company | Payments | Amount |
|---|---|---|
| Lumenis BE inc | 1 | $1,669 |
| ABBVIE INC. | 36 | $748 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $464 |
| Alkermes, Inc. | 19 | $440 |
| Janssen Pharmaceuticals, Inc | 15 | $395 |
| Collegium Pharmaceutical, Inc. | 12 | $258 |
| Neurocrine BioSciences, Inc. | 9 | $230 |
| Otsuka America Pharmaceutical, Inc. | 10 | $202 |
| Axsome Therapeutics, Inc. | 9 | $193 |
| Supernus Pharmaceuticals, Inc. | 12 | $166 |
Products named: M22, VRAYLAR, CAPLYTA, SPRAVATO, ARISTADA, Jornay PM, INGREZZA, REXULTI.
Industry payments across VA — which companies pay providers there.
